| Name | Title | Contact Details |
|---|
Since 2000, INSBANK has offered its clients highly personalized service provided by experienced relationship managers, while positioning itself as an innovator, utilizing technologies to deliver those services efficiently and conveniently. In addition to its commercial focused operation, INSBANK operates three divisions, Medquity, TMA Medical Banking and INSBANK Online. Medquity offers healthcare banking solutions nationwide to healthcare companies and to individuals, whether they are still in residency, practicing or entering retirement, while TMA Medical Banking provides banking services specifically to members of the Tennessee Medical Association. INSBANK Online offers nationally available virtual private client services for interest bearing deposits. INSBANK is owned by InsCorp, Inc., a Tennessee bank holding company, traded on the OTCQX under symbol IBTN.
LIV Golf is a global sports league featuring individual and team competition, a 14-tournament schedule, and many of the worlds best golfers. Founded in 2021, LIV Golf League was designed to expand the game on an international level and unlock the sports true economic and societal potential. Greg Norman, Hall of Fame golfer and renowned businessman, is the leagues first and founding CEO and Commissioner. With tournaments across North and Latin Americas, Asia, Australia, the Middle East and Europe, LIV Golf is growing and improving the game for fans and golfers alike. LIV Golf launched in 2022 as an eight-event ‘Invitational Series, while simultaneously backing The International Series as an exciting new addition to the Asian Tour. 2023 saw the inaugural LIV Golf League host 14 events around the world, from Adelaide to Chicago, Andalucía to Singapore, as well as launch the games first Team franchises, captained by some of golfs most decorated superstars. The format, respecting the historic traditions of the game, has been optimized for modern-day sports fans: 3 days, 54 holes, no cut, and a shotgun start - offering an immersive fan experience, with a faster pace of play to drive engaging storylines. In 2024, LIV Golf further expanded the reach of the League, splitting the schedule between some of the most iconic venues across Asia, Europe and the Middle East with decorated venues in the US. The full player pathway, created in partnership with the Asian Tour, also launched, with the games first ever player Promotion and Relegation and Player Transfer Window. Off the course, LIV Golf League is dedicated to enhancing the wellbeing of its communities through its ground-breaking social impact and sustainability strategy. ‘Potential, Unleashed reflects the leagues commitment to giving back and improving the world through golf.
Founded in 2018 and based near Green Bay, Wisconsin, closely held RC Mowers manufactures autonomous and remote-operated robotic mowers that solve the biggest challenges and improve opportunities for profitability and growth for landscaping contractors, public works departments, city, county, state and federal parks systems and roads departments, and more. All of our robotic mowers are designed and manufactured in the United States, have a 30-day buy-back guarantee and come with a 72-hour parts shipping guarantee. We are redefining the business of mowing.
A company dedicated to excellence in the insurance and financial services industries. Through data-driven management and lasting relationships, IH has built a solid foundation capable of taking companies to the next level of performance, profitability, and stability. Our business approach is straightforward. We believe that the power and success behind any business or industry lie within knowledge – knowledge of your products, the direction of your company, and the ongoing execution of a stellar strategic plan. These core assets, coupled with unmatched talent from a thriving corporate culture, are what we believe to be the key ingredients for achieving profitable, steady growth.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.